AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1887750 — intervention group
Group type: COMPARATOR
Intervention: Famotidine (one dose) and Placebo (one dose)
Number of subjects: 58
Study 1887750 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (any dose)
Number of subjects: 58
Study 6226186 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 32
Study 6226186 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa and hydrochlorothiazide combined
Number of subjects: 32
Study 6226186 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone
Number of subjects: 32
Study 31887369 — intervention group
Group type: EXPERIMENTAL
Intervention: Emricasan 5 mg
Number of subjects: 318
Study 31887369 — intervention group
Group type: EXPERIMENTAL
Intervention: Emricasan 50 mg
Number of subjects: 318
Study 31887369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318
Study 30221589 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered cognitive behavioural therapy (TCBT)
Number of subjects: 72
Study 30221589 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face cognitive behavioural therapy (CBT)
Number of subjects: 72
Study 30221589 — intervention group
Group type: COMPARATOR
Intervention: Both TCBT and CBT
Number of subjects: 72
Study 28941657 — intervention group
Group type: COMPARATOR
Intervention: Complex decongestive therapy (CDT)
Number of subjects: 40
Study 28941657 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex rehabilitation combined with complex decongestive therapy (CRCDT)
Number of subjects: 40
Study 24643137 — intervention group
Group type: EXPERIMENTAL
Intervention: ALADDIN platform
Number of subjects: 30
Study 24643137 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 22170885 — intervention group
Group type: EXPERIMENTAL
Intervention: Gufoni maneuver
Number of subjects: 157
Study 22170885 — intervention group
Group type: EXPERIMENTAL
Intervention: Head‐shaking maneuver
Number of subjects: 157
Study 22170885 — intervention group
Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 157
Study 19577008 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 211
Study 19577008 — intervention group
Group type: COMPARATOR
Intervention: White Light (WL)
Number of subjects: 211
Study 17582290 — intervention group
Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 515
Study 17582290 — intervention group
Group type: COMPARATOR
Intervention: CCABG
Number of subjects: 515
Study 15107413 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glutamine supplement (0.1 g/kg) given four times daily for the first 14 days
Number of subjects: 13
Study 15107413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 11059859 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone (50 mg/day)
Number of subjects: 8
Study 11059859 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg/day)
Number of subjects: 8
Study 9113182 — intervention group
Group type: EXPERIMENTAL
Intervention: esmolol 1 mg.kg‐1 + 200 micrograms.kg‐1.min‐1
Number of subjects: 40
Study 9113182 — intervention group
Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 40
Study 8096956 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine (24 mg/kg)
Number of subjects: 198
Study 8096956 — intervention group
Group type: COMPARATOR
Intervention: Mefloquine (25 mg/kg)
Number of subjects: 198
Study 8096956 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine (72 mg/kg, 8 mg/kg every 8 h for 3 days)
Number of subjects: 198
Study 8096956 — intervention group
Group type: EXPERIMENTAL
Intervention: Halofantrine (72 mg/kg)
Number of subjects: 198
Study 8096956 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Halofantrine (72 mg/kg)
Number of subjects: 198
Study 4036539 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.03 mg/kg p.o.
Number of subjects: 20
Study 4036539 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.02 mg/kg i.m.
Number of subjects: 20
Study 4036539 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study 2833543 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (150 mg daily for 6 weeks)
Number of subjects: 44
Study 2833543 — intervention group
Group type: COMPARATOR
Intervention: Maprotiline (150 mg daily for 6 weeks)
Number of subjects: 44
Study 29948420 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (CROSS cohort)
Number of subjects: 381
Study 29948420 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant chemoradiotherapy plus surgery (post-CROSS cohort)
Number of subjects: 381
Study 28879576 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy-strength training (HST) - 5 sets × 3 repetition maximum (RM)
Number of subjects: 14
Study 28879576 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertrophy training (HYT) - 3 sets × 12 RM
Number of subjects: 14
Study 28879576 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy-strength training (HST)
Number of subjects: 14
Study 28879576 — intervention group
Group type: COMPARATOR
Intervention: Control session (CON)
Number of subjects: 14
Study 25520426 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP (daily oral combination tenofovir disoproxil fumarate plus emtricitabine)
Number of subjects: 247
Study 25520426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 25520426 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP
Number of subjects: 247
Study 23088178 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical cognitive-behavioral stress management (SM)
Number of subjects: 89
Study 23088178 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive attention (SA)
Number of subjects: 89
Study 23088178 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 89
Study 21389754 — intervention group
Group type: EXPERIMENTAL
Intervention: STEPPS plus adjunctive individual therapy
Number of subjects: 168
Study 21389754 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 168
Study 18991076 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE/MPA (1.25 or 2.5 mg/day)
Number of subjects: 100
Study 18991076 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (1.25 or 2.5 mg/day)
Number of subjects: 100
Study 18991076 — intervention group
Group type: COMPARATOR
Intervention: CEE/MPA and Tibolone
Number of subjects: 100
Study 17151160 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5-20 mg/day)
Number of subjects: 112
Study 12843685 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amiodarone (group B)
Number of subjects: 106
Study 12843685 — intervention group
Group type: COMPARATOR
Intervention: Oral diltiazem (group A)
Number of subjects: 106
Study 12843685 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic drugs (group C)
Number of subjects: 106
Study 11938827 — intervention group
Group type: EXPERIMENTAL
Intervention: 912 compound (Chinese herbal preparation)
Number of subjects: 40
Study 11938827 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 9357941 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory evoked responses in preterm infants
Number of subjects: 81
Study 9357941 — intervention group
Group type: COMPARATOR
Intervention: Healthy term infants (control)
Number of subjects: 81
Study 9357941 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk preterm infants
Number of subjects: 81
Study 8226711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulphate 60 mg twice a day (Group 1)
Number of subjects: 159
Study 8226711 — intervention group
Group type: COMPARATOR
Intervention: Ferric polymaltose 100 mg daily (Group 2)
Number of subjects: 159
Study 8226711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric polymaltose 100 mg twice a day (Group 3)
Number of subjects: 159
Study 3513867 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP)
Number of subjects: 53
Study 29142243 — intervention group
Group type: EXPERIMENTAL
Intervention: GRStotal
Number of subjects: 707
Study 29142243 — intervention group
Group type: EXPERIMENTAL
Intervention: GRSwomen
Number of subjects: 707
Study 29142243 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGFA rs1358980‐T
Number of subjects: 707
Study 27366741 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Group
Number of subjects: 16
Study 27366741 — intervention group
Group type: EXPERIMENTAL
Intervention: Steam Group
Number of subjects: 16
Study 27366741 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 16
Study 25666686 — intervention group
Group type: EXPERIMENTAL
Intervention: Rusovastatin 40 mg
Number of subjects: 12
Study 25666686 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva sampling
Number of subjects: 12
Study 25666686 — intervention group
Group type: COMPARATOR
Intervention: Saliva
Number of subjects: 12
Study 23052531 — intervention group
Group type: EXPERIMENTAL
Intervention: LESS (Laparoendoscopic single-site surgery)
Number of subjects: 57
Study 23052531 — intervention group
Group type: COMPARATOR
Intervention: LC (Laparoscopic cholecystectomy)
Number of subjects: 57
Study 23052531 — intervention group
Group type: EXPERIMENTAL
Intervention: LESS
Number of subjects: 57
Study 23052531 — intervention group
Group type: COMPARATOR
Intervention: LC
Number of subjects: 57
Study 21964736 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoendoscopic single-site (LESS) cholecystectomy
Number of subjects: 150
Study 21964736 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic (CL) cholecystectomy
Number of subjects: 150
Study 18359360 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (up to 20 mg for 90 days)
Number of subjects: 60
Study 18359360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 18359360 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 60
Study 16988070 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-calorie diets (VLCDs) providing <800 kcal/d
Number of subjects: 6
Study 16988070 — intervention group
Group type: COMPARATOR
Intervention: Conventional low-calorie diets (LCDs)
Number of subjects: 6
Study 16988070 — intervention group
Group type: EXPERIMENTAL
Intervention: Very-low-calorie diets (VLCDs)
Number of subjects: 6
Study 14693489 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 1700
Study 14693489 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream
Number of subjects: 1700
Study 11026791 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental program in gerontology
Number of subjects: 0
Study 11026791 — intervention group
Group type: COMPARATOR
Intervention: Control site survey in Pézenas, Hérault
Number of subjects: 0
Study 10950471 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 70
Study 10950471 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 70
Study 10950471 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 70
Study 10950471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 8472226 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (no urinary diversion and urethral stents)
Number of subjects: 36
Study 8472226 — intervention group
Group type: COMPARATOR
Intervention: Control group (with urinary diversion and urethral stents)
Number of subjects: 36
Study 3530367 — intervention group
Group type: EXPERIMENTAL
Intervention: H/DHE (heparin sodium 5000 units plus dihydroergotamine mesylate 0.5 mg, twice a day)
Number of subjects: 269
Study 3530367 — intervention group
Group type: COMPARATOR
Intervention: LMWH/DHE (low molecular weight heparin 1500 units plus dihydroergotamine mesylate 0.5 mg, once a day)
Number of subjects: 269
Study 3530367 — intervention group
Group type: EXPERIMENTAL
Intervention: H/DHE
Number of subjects: 269
Study 3530367 — intervention group
Group type: COMPARATOR
Intervention: LMWH/DHE
Number of subjects: 269
Study 29904753 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid with 2% chlorhexidine (CHX) applied with Scotchbond Universal Adhesive (SBU)
Number of subjects: 80
Study 29904753 — intervention group
Group type: COMPARATOR
Intervention: 37% phosphoric acid (CTR) applied with Scotchbond Universal Adhesive (SBU)
Number of subjects: 80
Study 29904753 — intervention group
Group type: COMPARATOR
Intervention: 37% phosphoric acid (CTR) applied with Adper Single Bond 2 (SB2)
Number of subjects: 80
Study 29904753 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid with 2% chlorhexidine (CHX) applied with Adper Single Bond 2 (SB2)
Number of subjects: 80
Study 27531188 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT) procedure
Number of subjects: 136
Study 26697289 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic spinal manipulative therapy (CSMT)
Number of subjects: 120
Study 26697289 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham manipulation)
Number of subjects: 120
Study 26697289 — intervention group
Group type: COMPARATOR
Intervention: Control (usual non‐manual management)
Number of subjects: 120
Study 22826019 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's Appetite Awareness Training (CAAT)
Number of subjects: 47
Study 22826019 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 47
Study 20518178 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Hegu, Quchi, Neiguan, Zhigou) for 30 minutes
Number of subjects: 60
Study 20518178 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (Zusanli, Shangjuxu, Xiajuxu, Sanyinjiao) for 30 minutes
Number of subjects: 60
Study 20518178 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture (Control group)
Number of subjects: 60
Study 19294863 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhizhuwan (ZZ) 90 g per day for 1 month
Number of subjects: 28
Study 19294863 — intervention group
Group type: COMPARATOR
Intervention: Cisapride 30 mg per day for 1 month
Number of subjects: 28
Study 16905552 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored pre-operative intervention for excessive alcohol consumption (n = 45)
Number of subjects: 136
Study 16905552 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group, n = 91)
Number of subjects: 136
Study 12952112 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine hydrochloride (180 mg)
Number of subjects: 259
Study 12952112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study 11009855 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of mammography guidelines
Number of subjects: 2239
Study 11009855 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of Pap smear guidelines
Number of subjects: 2239
Study 11009855 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes toward cancer
Number of subjects: 2239
Study 11009855 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening participation
Number of subjects: 2239
Study 8712292 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal anaplasia (FA)
Number of subjects: 165
Study 8712292 — intervention group
Group type: COMPARATOR
Intervention: Diffuse anaplasia (DA)
Number of subjects: 165
Study 1930916 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal clonidine (Catapres‐TTS)
Number of subjects: 16
Study 1930916 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine
Number of subjects: 16
Study 1930916 — intervention group
Group type: COMPARATOR
Intervention: Transdermal clonidine
Number of subjects: 16
Study 6890761 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc acetate supplementation
Number of subjects: 24
Study 6890761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31733990 — intervention group
Group type: EXPERIMENTAL
Intervention: 25mg/d mirabegron
Number of subjects: 100
Study 31733990 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 100
Study 31623223 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-week Mediterranean diet intervention (MD) for non-adherers from the UK
Number of subjects: 2
Study 31623223 — intervention group
Group type: COMPARATOR
Intervention: Control group (long-term MD adherers from Greece)
Number of subjects: 2
Study 28441856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin combined with somatostatin
Number of subjects: 42
Study 28441856 — intervention group
Group type: COMPARATOR
Intervention: Somatostatin (control)
Number of subjects: 42
Study 25302551 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of death scale (Study 1)
Number of subjects: 236
Study 25302551 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing about own death (Study 2)
Number of subjects: 236
Study 25302551 — intervention group
Group type: COMPARATOR
Intervention: Public speaking scale (Study 1)
Number of subjects: 236
Study 25302551 — intervention group
Group type: COMPARATOR
Intervention: Writing about dental pain (Study 2)
Number of subjects: 236
Study 23170828 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 358
Study 23170828 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 358
Study 23170828 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 358
Study 21777884 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 593
Study 21777884 — intervention group
Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 593
Study 19622627 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (1.0 mg/m² . d)
Number of subjects: 46
Study 19622627 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 16700848 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedated group
Number of subjects: 58
Study 16700848 — intervention group
Group type: COMPARATOR
Intervention: Nonsedated group
Number of subjects: 58
Study 16700848 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 58
Study 15605000 — intervention group
Group type: COMPARATOR
Intervention: 15 to 25 mL injection of 1:10,000 solution of epinephrine
Number of subjects: 72
Study 15605000 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 to 45 mL injection of 1:10,000 solution of epinephrine
Number of subjects: 72
Study 15605000 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 to 45 mL injection of 1:10,000 solution of epinephrine for gastric body ulcers
Number of subjects: 72
Study 15605000 — intervention group
Group type: COMPARATOR
Intervention: 15 to 25 mL injection of 1:10,000 solution of epinephrine for gastric body ulcers
Number of subjects: 72
Study 11574380 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified subgluteus posterior approach
Number of subjects: 128
Study 11574380 — intervention group
Group type: COMPARATOR
Intervention: Classic posterior sciatic nerve block (Group Labat)
Number of subjects: 128
Study 9138173 — intervention group
Group type: COMPARATOR
Intervention: Cremophor EL-solubilized preparation of vitamin K1 (Konakion drops)
Number of subjects: 30
Study 9138173 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-micellar preparation of vitamin K1 (Konakion MM)
Number of subjects: 30
Study 9138173 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 30
Study 8834961 — intervention group
Group type: EXPERIMENTAL
Intervention: School of asthma (22 patients attended the school)
Number of subjects: 360
Study 8834961 — intervention group
Group type: COMPARATOR
Intervention: Control group (22 patients did not attend the school)
Number of subjects: 360
Study 2083195 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 50 mg plus amiloride 5 mg (HA)
Number of subjects: 18
Study 2083195 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 5 mg twice daily (F)
Number of subjects: 18
Study 2083195 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine ER 10 mg daily (FER)
Number of subjects: 18
Study 378011 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal drains
Number of subjects: 100
Study 378011 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tubes
Number of subjects: 100
Study 378011 — intervention group
Group type: COMPARATOR
Intervention: No intraperitoneal drain
Number of subjects: 100
Study 30678029 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey proteins
Number of subjects: 9
Study 30678029 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrins
Number of subjects: 9
Study 29197218 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic acupuncture
Number of subjects: 196
Study 29197218 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 196
Study 29197218 — intervention group
Group type: COMPARATOR
Intervention: Low-calorie diet alone
Number of subjects: 196
Study 25629803 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (8-week group intervention including mindfulness, gentle yoga, and music)
Number of subjects: 0
Study 25629803 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 25123755 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate/severe diabetic retinopathy (DR)
Number of subjects: 3369
Study 25123755 — intervention group
Group type: EXPERIMENTAL
Intervention: No/mild diabetic retinopathy (DR)
Number of subjects: 3369
Study 22190065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg b.i.d. for 5 days)
Number of subjects: 24
Study 22190065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 20081560 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for spinal stenosis
Number of subjects: 0
Study 20081560 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment for spinal stenosis
Number of subjects: 0
Study 20081560 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for spinal stenosis with degenerative spondylolisthesis
Number of subjects: 0
Study 17430285 — intervention group
Group type: EXPERIMENTAL
Intervention: arts‐based observational skills training for 90 minutes
Number of subjects: 68
Study 17430285 — intervention group
Group type: COMPARATOR
Intervention: practical training in the management of psoriasis
Number of subjects: 68
Study 15897164 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate baths
Number of subjects: 31